Pharmaceuticals receive direct injection
Oct 14, 2009
Staff and wire reports
RIGA - In a boost of confidence to Latvia’s leading pharmaceuticals company, global mutual fund investment company Templeton Asset Management has acquired a significant number of shares in Grindeks, reports news agency LETA. Grindeks is the largest pharmaceutical company in the Baltic states. The company specializes in production and sales of cardiovascular, psychotropic and anticancer drugs, producing both final dosage form pharmaceuticals and active ingredients.
The company reported weak f ...
The article you requested can be accessed only by subscribing to the online version of
The Baltic Times. If you are already subscribed to
The Baltic Times, please log on using the form on the top of the page. If you do not have a membership yet - please
subscribe